Skip to main content
. 2021 Mar 17;2021:8395048. doi: 10.1155/2021/8395048

Table 2.

Biomarker profiles in sepsis patients at baseline (n = 30).

Parameter Median IQR (25th-75th quartile)
Inflammatory mediators
 IL-1β (pg/ml) 6.82 4.37-14.55
 IL-1ra (pg/ml) 670.66 266.44-1,231.08
 IL-2 (pg/ml) 7.62 1.12-32.42
 IL-4 (pg/ml) 6.36 4.82-10.11
 IL-5 (pg/ml) 19.94 15.94-35.56
 IL-6 (pg/ml) 277.02 103.65-1,091.49
 IL-7 (pg/ml) 8.14 4.64-22.54
 IL-8 (pg/ml) 104.56 53.26-198.48
 IL-9 (pg/ml) 15.76 8.62-34.04
 IL-10 (pg/ml) 28.48 10.59-65.04
 IL-12 (pg/ml) 19.54 8.71-45.81
 IL-13 (pg/ml) 6.68 0.84-11.68
 IL-15 (pg/ml) 14.30 1.36-57.00
 IL-17 (pg/ml) 49.22 19.65-86.74
 IFN-γ (pg/ml) 173.40 112.79-295.45
 TNF-α (pg/ml) 84.56 44.98-152.19
 CRP (mg/l) 208.15 164.26-283.67
 PCT (ng/ml) 3.00 0.78-4.36
 LBP (μg/ml) 114.93 77.47-172.14
 sCD14 (ng/ml) 3,159.00 2,728.00-3,721.00
 sST2 (ng/ml) 372.36 173.64-589.74
 Gas6 (ng/ml) 43.15 34.03-55.44
Chemokines
 MCP-1 (pg/ml) 125.72 49.97-385.93
 MIP-1α (pg/ml) 8.48 5.72-12.92
 MIP-1β (pg/ml) 120.94 96.09-200.34
 RANTES (pg/ml) 2,014.36 1,088.59-3,285.85
 Eotaxin (pg/ml) 95.78 59.67-116.16
 IP-10 (pg/ml) 1,375.94 822.83-2,734.51
Growth factors
 G-CSF (pg/ml) 161.60 70.82-637.97
 GM-CSF (pg/ml) 54.32 13.46-109.47
 FGF (pg/ml) 79.94 56.00-116.24
 PDGF (pg/ml) 118.70 68.22-218.79
 VEGF (pg/ml) 25.98 10.39-60.54
Endothelial activation markers
 ESM-1 (ng/ml) 6.00 3.86-12.95
 Ang-1 (ng/ml) 0.59 0.43-1.22
 Ang-2 (ng/ml) 13.85 7.85-33.21
 Ang-2/Ang-1 22.99 8.96-61.99
Damage-associated molecular patterns
 ecDNAa (ng/ml) 545.02 276.11-1,194.48
 Histonesa (mg/ml) 6.60 0.45-24.67
 HMGB-1b (ng/ml) 3.70 2.6-6.91
Coagulation-related parameters
 TF (pg/ml) 66.98 50.64-91.59
 TF activity (pM) 38.13 24.57-55.79
Others
 Cystatin C (μg/ml) 3.75 2.92-4.05
 Albumin (g/dl) 3.38 2.83-3.81

Data are represented as median and interquartile range (IQR, 25th-75th quartile). an = 29; bn = 27.